Amber Watson

DNP Doctor of Nursing Practice,  Toronto General - University Health Network 

Location: Africa

Consulting Services

Career Advice and Mentoring Sales and Marketing

Areas Of Interest

Tumor Genes, Wilms Program, Managed Care Oral Rehydration Therapies Anorectal Atresias Eczema-Thrombocytopenia-Immunodeficiency Syndrome Strength, Muscle Acid, Aurin Tricarboxylic Process, Virus Physiological Monocyte Chemotactic Protein 2 Spirono Isis Obzidan Douc Langurs Arsenic Poisoning Employee Performance Appraisal G alpha Protein q Ophthalmoplegia, Supraoptic Vertical Congenital Fiber Type Disproportion Program, Syringe-Exchange MAP1 Microtubule-Associated Protein MELAS Studies, Incidence Epstein-Barr Virus Receptor Seabreams, Gilthead Positive Pressure Respiration, Non Therapeutic Cells, THP-1 Peripheral Devices, Computer Novo Maprotiline Vertical-Banded Gastroplasties Close Call, Healthcare Twelfth Cranial Nerve Injury Bisacodyl Uniserts Surgical Fasteners Antigen, OKM5 Norwood Procedure, Stage 3 Scanners, X-Ray CAT Collagen Type V, alpha3 Subunit

Professional Narrative

Dr. Amber Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 2018
Medical Writer, Harvard Med 1989

Education

Doctor of osteopathic medicine, Perelman School of Medicine 2000
Master of Science in physician assistant, Baylor College 2005

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :